Home R&D Page 8

R&D

Phase 2 Trial of Tarextumab in Small Cell Lung Cancer Does...

Evolocumab: lowering LDL-C to unprecedented levels did not negatively impact cognition

EMA approved tofacitinib for moderate to severe rheumatoid arthritis

First biologic medicine approved for adults with moderate-to-severe atopic dermatitis

The fight against antimicrobial resistance starts in the pharmaceutical plant

A Swedish collaboration against mitochondrial myopathy

New combo empagliflozin and linagliptin in type 2 diabetes

Palbociclib to treat breast cancer

Omecamtiv mecarbil Phase 2 results in chronic heart failure

Alirocumab ODYSSEY trial on alirocumab will continue as planned following interim...

1...789...17Page 8 of 17
© © 2025 Tecniche Nuove Spa - All rights reserved. Registered office: Via Eritrea 21 - 20157 Milan. Share capital: 5,000,000 Euro fully paid up. Tax code, VAT number and registration with the Milan Register of Companies: 00753480151